
Braveheart Bio CFO buys 27,777 shares for $500K, hinting at strong IPO performance.
Braveheart Bio's CFO recently purchased 27,777 shares at a total cost of $500,000. This significant insider buying suggests confidence in the company's future and may indicate that the recent IPO was successful. Investors often view such insider purc...


